Waters Corporation (WAT) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Waters Corporation on March 16, 2026. The filing relates to the acquisition of the Biosciences and Diagnostic Solutions business (the "SpinCo Business") from Becton, Dickinson and Company, which was completed on February 9, 2026. The report serves to provide financial data in connection with an expected Form S-3 registration statement.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. Instead, it incorporates by reference the following unaudited financial documents regarding the acquired SpinCo Business and pro forma combined results:
- Condensed combined financial statements as of December 31, 2025, and September 30, 2025.
- Results of operations for the three months ended December 31, 2025, and 2024.
- Management's Discussion and Analysis (MD&A) for fiscal years ended September 30, 2025, 2024, and 2023.
- Unaudited pro forma condensed combined financial information as of and for the fiscal year ended December 31, 2025.
Material Changes
The primary material change is the acquisition of the SpinCo Business on February 9, 2026. This transaction expands Waters' portfolio into the biosciences and diagnostic solutions sector previously held by Becton, Dickinson and Company. The filing provides the necessary financial history of this acquired entity to allow investors to assess the combined entity's performance.
Guidance, Outlook, and Risks
The filing does not contain specific forward-looking guidance, management commentary on future outlook, or a detailed discussion of risks and contingencies within the main text. Such information is expected to be contained within the incorporated exhibits (Exhibits 99.2 and 99.3) and the upcoming Form S-3 registration statement. The filing notes the expectation to file the S-3 promptly after this 8-K.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited financial statements of the acquired SpinCo Business.
- Analyze Exhibit 99.4 for pro forma financial information to understand the combined entity's financial position as of December 31, 2025.
- Examine Exhibits 99.2 and 99.3 for detailed MD&A regarding the SpinCo Business's historical performance and operational results.
- Monitor the subsequent filing of the Form S-3 registration statement for updated guidance and risk factors.